-

Biocom California Statement on Silicon Valley Bank

SAN FRANCISCO & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the life science industry of California, issued the following statement regarding the collapse of Silicon Valley Bank. The statement can be attributed to Joe Panetta, Biocom California’s president and CEO:

“The collapse of Silicon Valley Bank (SVB) and upheaval in the banking sector has created difficulties for many in the life science industry in California and beyond. We know that some of our 1,700 members have been impacted by this sudden and unexpected development. California companies develop groundbreaking new medicines and our ecosystem is not only extremely important to our state and the nation, but also to patients with medical needs around the world. The recent actions by the Federal Reserve, the FDIC, and Treasury to allow SVB depositors to have access to all their money is a very positive development to mitigate the potential harm to California companies that are innovating across the bioeconomy.

We will continue to monitor the situation and encourage our members to reach out to us.”

About Biocom California

Biocom California is the leader and advocate for California’s life science sector. We work on behalf of more than 1,700 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs.

Founded in 1995 in San Diego, Biocom California provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom California operates core offices in Los Angeles and the San Francisco Bay Area, with satellite offices in Sacramento, Washington, D.C. and Tokyo. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.

For more information on Biocom California, please visit our website at www.biocom.org. Connect with us on LinkedIn, Facebook, and Twitter (@BIOCOMCA).

Contacts

Biocom California Media Contact:
Carolyn Hawley
Evoke Canale
(619) 849-5382
Carolyn.hawley@evokegroup.com

Biocom California


Release Versions

Contacts

Biocom California Media Contact:
Carolyn Hawley
Evoke Canale
(619) 849-5382
Carolyn.hawley@evokegroup.com

Social Media Profiles
More News From Biocom California

Biocom California Establishes International Collaboration with BPI to Bolster Cooperation Between Both Organizations

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the California life science industry, today announced the signing of a memorandum of understanding (MOU) with Bundesverband der Pharmazeutischen Industrie e.V. (BPI), Germany’s national industry association representing the pharmaceutical industry. BPI is headquartered in Berlin and represents the interest of approximately 260 pharmaceutical and biotech companies in Germany. “...

Biocom California Calls for Nominations for the Ninth Annual Life Science Catalyst Awards

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the California life science industry, today called for entries for the ninth annual Life Science Catalyst Awards. The awards celebrate rising and accomplished academics, entrepreneurs, investors, corporate leaders and business advisers who are making significant contributions to the life science industry in California before reaching their 40th birthday. “The Catalyst Awards r...

Tim Scott to Succeed Joe Panetta as Biocom California President and CEO

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the California life science industry, today announced that it has named Tim Scott as its president and CEO, effective January 1, 2025. Mr. Scott will succeed Joe Panetta, Biocom California’s current president and CEO, who has led the organization for 25 years. Mr. Scott has been active on the board of directors for Biocom California since 2010, having served as the board’s cha...
Back to Newsroom